Cargando…
Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276226/ https://www.ncbi.nlm.nih.gov/pubmed/32525000 http://dx.doi.org/10.1016/j.jinf.2020.06.007 |
| _version_ | 1783542919916945408 |
|---|---|
| author | Li, Gerui |
| author_facet | Li, Gerui |
| author_sort | Li, Gerui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7276226 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72762262020-06-08 Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19 Li, Gerui J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2020-08 2020-06-07 /pmc/articles/PMC7276226/ /pubmed/32525000 http://dx.doi.org/10.1016/j.jinf.2020.06.007 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Li, Gerui Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19 |
| title | Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19 |
| title_full | Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19 |
| title_fullStr | Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19 |
| title_full_unstemmed | Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19 |
| title_short | Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19 |
| title_sort | aspartate aminotransferase: a prognostic marker rather than a specific liver injury marker in covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276226/ https://www.ncbi.nlm.nih.gov/pubmed/32525000 http://dx.doi.org/10.1016/j.jinf.2020.06.007 |
| work_keys_str_mv | AT ligerui aspartateaminotransferaseaprognosticmarkerratherthanaspecificliverinjurymarkerincovid19 |